MedTrace Logo

Thailand ATTR-CM Registry

NCT06338696 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-05-08

No results posted yet for this study

Summary

The investigators of this registry aim to study the natural history, clinical presentation, characteristics, and imaging findings of patients diagnosed with ATTR amyloidosis in Thailand longitudinally. This will enable the investigators to study this disease in depth. With a better understanding, the investigators can aim to develop early screening programs for at-risk patients, raising awareness among non-cardiologists. As amyloid-specific therapies have now become available in Thailand, the findings of this registry can be helpful for epidemiological studies in Thailand.

Conditions

  • Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Mahidol University

    lead OTHER

Principal Investigators

  • Rungroj Krittayaphong, MD, FESC, FACC · Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2029-06-01
Completion
2030-06-30

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06338696 on ClinicalTrials.gov